IP And Trademarks 23 September 2026
ENTOD Pharma Wins Patent for Insulin Eye Drop
ENTOD Pharmaceuticals has secured Indian Patent No. 595378 for its insulin eye drop, a first in ocular drug delivery. The patent covers the formulation and method, enabling the firm to push diabetic eye‑care treatments and explore market opportunities.
ENTOD Pharma has been awarded Indian Patent No. 595378 for its insulin eye‑drop formulation, the first of its kind to deliver insulin directly to the eye.
- Protects both the drug composition and the delivery method.
- Targets diabetic eye complications with a non‑invasive option.
- Positions ENTOD to seek approvals and expand into global markets.
*Read more at* New Indian Express.
Need help understanding this update?
Connect with our domain experts instantly via WhatsApp for customized legal guidance.